Abstract
Personalized treatments have become a primary goal in translational psychiatric research. They include the identification of neural circuits associated with psychiatric disorders and definition of treatment according to individual characteristics. Many new tools and technologies have been developed but further efforts are required to provide clues on how these scientific advances in psychiatry may be translated into more effective therapeutic approaches. Obstacles to the progress of translational psychiatry also involve numerous scientific, financial, ethical, logistics and regulatory aspects. Also, the goal of DSM-5 to expand " signs and symptoms" classification to incorporate biological measures may help the development of new multifactorial and dimensional models able to better understand the pathophysiology of psychiatric disorders and develop improved treatments. Finally, a better understanding on the significant response variability, cognitive functioning, role of comorbidities and treatment-resistant cases are critical for the development of prevention and intervention strategies that are more effective. © 2012 Machado-Vieira; licensee BioMed Central Ltd.
Author supplied keywords
Cite
CITATION STYLE
Machado-Vieira, R. (2012, August 28). Tracking the impact of translational research in psychiatry: State of the art and perspectives. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-10-175
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.